← Back to Patent Explorer
US5866561A Expired / Lapsed US ⏱️ 0.0 years remaining

Local delivery of estrogen for angiogenesis

Assignee: Boston Scientific Scimed Inc
•
Filing: 1997-08-21
•
Granted: 1999-02-02
•
Expires: 2017-08-21
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A method for inducing angiogenesis in blood vessels proximal to ischemic tissue or proximal to stenosed regions including application of an estrogen compound to the blood vessel walls at a treatment site proximal to or upstream of the stenosis. A preferred delivery device is a double walled drug delivery catheter having porous outer walls. Another suitable delivery device is a drug injection device for injecting angiogenic material into blood vessel walls. One delivery method utilizes iontophoresis.

Inventors

  • 👤 Mark T. Ungs

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-31 08:43
CPC Classifications
A; A61; A61L; A61L29/00; A61L29/14; A61L29/16; A61K; A61K31/00; A61K31/56; A61K31/565; A61L2300/00; A61L2300/20; A61L2300/22; A61L2300/222; A61L2300/40; A61L2300/412

Claims Analysis

Total Claims: 10
Claim 1
Independent Claim 52 words
A method for increasing blood flow to ischemic tissue proximal to a constricted blood vessel region comprising the step of inducing angiogenesis in a less constricted blood vessel region proximal to said constricted region by applying an effective amount of estrogen compound for causing angiogenesis to said less constricted blood vessel region.
Claim 2
Independent Claim 52 words
A method for increasing blood flow to ischemic tissue proximal to a constricted blood vessel region comprising the step of inducing angiogenesis in a less constricted blood vessel region proximal to said constricted region by applying an effective amount of estrogen compound for causing angiogenesis to said less constricted blood vessel region.
Claim 3
Dependent Claim 22 words
The method of claim 1, wherein said method further comprises providing an application device, wherein said application device is a balloon catheter.
Claim 4
Dependent Claim 25 words
The method of claim 1, wherein said less constricted blood vessel region has walls and said applying step includes depositing said compound on said walls.
Claim 5
Dependent Claim 20 words
The method of claim 1, wherein said applying device is a double walled balloon catheter having a porous outer wall.
Claim 6
Dependent Claim 12 words
The method of claim 4, wherein said catheter includes a perfusion lumen.
Claim 7
Dependent Claim 32 words
The method of claim 1, wherein said less constricted blood vessel region has walls, said application device is an injection device, and said applying step includes injecting said compound into said walls.
Claim 8
Dependent Claim 19 words
The method of claim 1, wherein said estrogen compound is selected from the group consisting of estradiol(E2) and estriol(E3).
Claim 9
Dependent Claim 12 words
The method of claim 1, wherein said estrogen compound is 17-Beta Estrodiol.
Claim 10
Dependent Claim 48 words
The method of claim 1, wherein said less constricted blood vessel region has walls, and said method includes providing an application device including an iontophoresis device and said applying step includes depositing said compound on said walls and transporting said compound through said walls utilizing said iontophoresis device.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2002-02-01 2002-08-03 2003-02-02 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2006-02-01 2006-08-03 2007-02-02 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2010-02-01 2010-08-03 2011-02-02 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag